GoodRx Holdings (GDRX) Interest & Investment Income (2019 - 2026)

GoodRx Holdings has disclosed Interest & Investment Income across 8 years of filings, most recently posting $1.0 million for Q2 2026.

• In Q2 2026, Interest & Investment Income fell 63.65% year-over-year to $1.0 million; the TTM figure through Jun 2026 stood at $6.6 million (down 58.97% YoY), while the FY2025 annual figure was $10.9 million, down 53.02% from the prior year.
• Interest & Investment Income came in at $1.0 million for Q2 2026 at GoodRx Holdings, down from $1.4 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $8.6 million in Q3 2023 to a low of $52000.0 in Q1 2022.
• Average Interest & Investment Income over 5 years is $4.3 million, with a median of $4.3 million recorded in 2024.
• Year-over-year, Interest & Investment Income surged 31929.41% in 2022 and tumbled 64.47% in 2026.
• Over 5 years, Interest & Investment Income stood at $5.4 million in 2022, then surged by 55.63% to $8.5 million in 2023, then sank by 45.87% to $4.6 million in 2024, then slumped by 58.82% to $1.9 million in 2025, then tumbled by 46.06% to $1.0 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $1.0 million in Q2 2026, $1.4 million in Q1 2026, and $1.9 million in Q4 2025.